Cambridge UK online investment platform SyndicateRoom is giving its members the opportunity to take part in a £5.2 million Series B funding round by Irish medtech business Hibergene Diagnostics, alongside its lead investor.
Hibergene, based in Dublin, specialises in the urgent diagnostics of potentially fatal infectious diseases and is acquiring funds for global expansion and further product development.
It is the largest round SyndicateRoom has given its members the opportunity to invest in so far. It also represents a shift into later stage for SyndicateRoom’s private markets business, being its first Series B.
For more, please follow this link.